Senisca
Latest round
- Seed
Last raised
- Feb 2024
Total raised
- $7.5M
Investors
- 7
About Senisca
Based in the UK, and founded in 2020 by CSO, Professor Lorna Harries, CTO, Ben Lee, and CEO, Kirsty Semple, Senisca Ltd, formed as a spinout company from the University of Exeter, operates as a provider of a new generation of senotherapeutic procedures to treat the diseases and aesthetic signs of ageing. The company offers oligonucleotide-based therapeutic solutions used for the treatment of age-related diseases, helping reduce disease incidence and severity. The company is working on druggable means to reverse senescence through the modulation of RNA splicing.
Who invested in Senisca
7 investors across 2 rounds
See all investors in Senisca
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Senisca
Who invested in Senisca?
Senisca has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Senisca raised?
Senisca has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Senisca last raise money?
Senisca's most recent round on record is a Seed, in Feb 2024.
What does Senisca do?
Based in the UK, and founded in 2020 by CSO, Professor Lorna Harries, CTO, Ben Lee, and CEO, Kirsty Semple, Senisca Ltd, formed as a spinout company from the University of Exeter, operates as a provider of a new generation of senotherapeutic procedures to treat the diseases and aesthetic signs of ageing.
Where is Senisca headquartered?
Senisca is headquartered in Exeter, UK.
Which VCs invest in companies like Senisca?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Senisca's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Senisca? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.